(Press-News.org) Population-wide levels of HIV virus dropped substantially between 2011 and May 2012 in a rural part of southwestern Uganda, the site of two community health campaigns led by doctors at the University of California, San Francisco (UCSF), San Francisco General Hospital and Trauma Center (SFGH) and Makerere University in Kampala, Uganda.
The campaign, which was part of the Sustainable East Africa Research in Community Health (SEARCH) Collaboration, involved free counseling, testing for HIV and other diseases, linkage to care and treatment. This comprehensive approach to addressing HIV/AIDS has been pioneered in San Francisco over the last few years.
Mounting evidence is showing that universal testing and early treatment for HIV can help keep people healthier longer and can reduce the spread of HIV within communities.
In a talk to be presented on Tuesday, July 24, 2012 at the XIX International AIDS Conference in Washington, D.C., members of the UCSF research team will describe early results of their campaign in one resource-limited setting in sub-Saharan Africa, where 60 percent of the world's HIV-infected people reside.
Their effort involved two large community health campaigns in May 2011 and May 2012, in which every resident in a southwestern Ugandan district called Kakyerere Parish (population 6,300) was offered free counseling, testing for HIV and other diseases, and linkage to care. Between the two campaigns, there was a substantial drop in the amount of HIV virus measured in the community.
In 2011, 37 percent of HIV-positive persons had undetectable levels of virus, and by 2012 that number had risen to 55 percent. By contrast, only an estimated 20-30 percent of the people in the United States who are infected have undetectable levels of HIV—in part because 1 in 5 Americans living with HIV do not know they are infected.
"Viral loads in the population can be a readout of how we are doing with HIV care across the whole district," said Vivek Jain, MD, MAS, assistant professor of medicine in the UCSF Division of HIV/AIDS at SFGH. "More people in Uganda are accessing therapy, and the therapy they are accessing is achieving success."
What the SEARCH Study Found
In the 2012 study, 4,872 total people (2,271 adults) were tested for HIV over a one-week period, and 210 community adults tested positive for HIV. Those who tested positive were given a separate test to determine the amount of virus in their bloodstream—a quantity known as "viral load."
The scientists employed a new method for measuring viral load on-site by taking four drops of blood through a simple finger prick, avoiding the need for standard, more time consuming blood draw procedures that use needles.
After the original health campaign in May 2011, the group conducted a second parish-wide testing campaign in May 2012. Within one year, there had been a substantial reduction in viral loads in the population.
"Every way you look at it, there is less virus in this community," said Diane Havlir, MD chief of the UCSF Division of HIV/AIDS at SFGH and co-director of the SEARCH Collaboration.
There were several possible reasons for the drop in virus, said Jain. To begin with, the community health campaign of 2011 helped identify more people who were infected (including many people who previously did not know they were HIV-positive), and helped link them to medical care. Second, the government of Uganda recently changed the guidelines for offering treatment to allow access to antiretroviral drugs earlier in the course of the HIV disease process, at a higher T cell count threshold.
Finally, people in the community who did not qualify for drugs under the Ugandan government guidelines were nevertheless given access to antiretroviral therapy through a research study also being conducted by the SEARCH group in the district: this study offers therapy to persons at any T cell count, creating an option for residents to access therapy even if their T cell counts are still high.
To build on these encouraging pilot results, said Jain, a large clinical study is needed to rigorously study whether the reduction in virus levels in the population is a direct result of the community health campaign and the expanded access to HIV medicines in the district.
###
The late-breaker talk, "Changes in population-level HIV RNA distribution one year after implementation of key components of an HIV 'test and treat' strategy in rural Uganda" by V. Jain, D. Kwarisiima, T. Liegler, T. Clark, G. Chamie, J. Kabami, D. Black, G. Amanyire, D. Byonanebye, E. Geng, H. Thirumurthy, M. Petersen, E. Charlebois, M. Kamya, D. Havlir, and the SEARCH Collaboration will be presented at the XIX International AIDS Conference in Washington, D.C. at 11:00 a.m. ET on Tuesday, July 24, 2012 in Mini Room 9. ABSTRACT: http://pag.aids2012.org/abstracts.aspx?aid=21119
In addition to UCSF and SFGH, authors of this study are associated with the Makerere University-University of California, San Francisco (MU-UCSF) Research Collaboration in Kampala, Uganda, the Mulago-Mbarara Teaching Hospitals' Joint AIDS Program (MJAP) in Kampala, Uganda, the University of California, Berkeley and the University of North Carolina, Chapel Hill. The work was funded by the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
Follow UCSF
UCSF.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf
END
Charlottesville, VA (July 24, 2012). Researchers at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire have found an association between increasing the distribution of neurosurgeons throughout the United States and decreasing the risk of death from motor vehicle accidents (MVAs). The findings of their study are described in the article "Increased population density of neurosurgeons associated with decreased risk of death from MVAs in the United States. Clinical article," by Atman Desai, M.D., and colleagues, published today online, ahead of print, in the Journal ...
COLUMBUS, Ohio -- Chronic exposure to dim light at night can lead to depressive symptoms in rodents -- but these negative effects can be reversed simply by returning to a standard light-dark cycle, a new study suggests.
While hamsters exposed to light at night for four weeks showed evidence of depressive symptoms, those symptoms essentially disappeared after about two weeks if they returned to normal lighting conditions.
Even changes in the brain that occurred after hamsters lived with chronic light at night reversed themselves after returning to a more normal light ...
The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say.
Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle University found that a routine test in the home revealed that around a quarter of them had undiagnosed heart problems which could be treated with established and cost-effective treatments.
In the study, funded by the British Heart Foundation (BHF), the team visited the homes of 376 people aged 87 to 89 years old and carried ...
The truth behind some of the world's most famous historical myths, including Homer's epic, the Iliad, has been bolstered by two researchers who have analysed the relationships between the myths' characters and compared them to real-life social networks.
In a study published online today, 25 July, in the journal EPL (Europhysics Letters), Pádraig Mac Carron and Ralph Kenna from Coventry University performed detailed text analyses of the Iliad, the English poem, Beowulf, and the Irish epic, the Táin Bó Cuailnge.
They found that the interactions between the characters ...
Programmed cell death (PCD) is a highly regulated process that occurs in all animals and plants as part of normal development and in response to the environment. New research published in BioMed Central's open access journal BMC Plant Biology is the first to document the physiological events in the lace plant (Aponogeton madagascariensis) which occur via PCD to produce the characteristic holes in its leaves.
The aquatic lace plant, endemic to Madagascar, uses PCD to generate holes in its leaves. Researchers from Dalhousie University, Nova Scotia, used long-term live ...
Of 63,942 new cases of cutaneous melanoma (a form of skin cancer) diagnosed each year in Europe an estimated 3,438 (5.4%) are related to sunbed use. Sunbed users are at a 20% increased relative risk of skin cancer compared with those who have never used a sunbed. This risk doubles if they start before the age of 35 and experts warn that "tougher actions" are needed to reduce this risk.
Sun exposure is the most significant environmental cause of skin cancer and sunbeds have become the main non-solar source of UV exposure in Western Europe (UV is the wavelength associated ...
Research: Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24,827 people: systematic review and meta-analysis
Tools designed to predict an individual's risk of repeat offending are not sufficient on their own to inform sentencing and release or discharge decisions, concludes a study published on bmj.com today.
Although they appear to identify low risk individuals with high levels of accuracy, the authors say "their use as sole determinants of detention, sentencing, and release is not supported by the current evidence."
Risk ...
Research: Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study
Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published on bmj.com today.
With more than two billion people at risk of malaria in this part of Asia – larger than that of Africa - this is a major public health problem which needs to be confronted, say the authors.
Malaria remains one of the most important infectious diseases of poverty. Recent global malaria treatment ...
CHICAGO --- A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain.
Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that has recently completed the first human Phase 1 clinical trial for the drug.
The drugs in this class target a particular type of brain inflammation, ...
BOSTON (July 24, 2012, 5:00PM EST)—A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow ...